Q. Describe Anthracycline Cardiomyopathy?
It is due to anticancer agent doxorubion (Adriamycine), when the cumulative dose exceeds 450 mg/m2 in subjects with normal hearts. In presence of heart disease or other risk factors viz. prior mediastinal radiation or when radiation treatment follows chemotherapy, the cardiomyopathy can occur at lower dosage.